Skip to Main Content

Paper Details

Low-risk penicillin allergy delabeling through a direct oral challenge in immunocompromised and/or multiple drug allergy labeled patients in a critical care setting.
J Allergy Clin Immunol Pract
10
2022
immunocompromised, multiple drug allergy, patients, penicillin
Anti-Bacterial Agents, Critical Care, Drug Hypersensitivity, Humans, Penicillins, Skin Tests
Author NameAffiliation
Grace KooVanderbilt University Medical Center
Joanna L StollingsDepartment of Pharmaceutical Services, Vanderbilt University Medical Center
Christopher J LindsellVanderbilt University Medical Center, Tenn Vanderbilt Institute for Clinical and Translational Research
Mary Lynn DearVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Mary Lynn DearVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Sunil KripalaniSection of Hospital Medicine, Vanderbilt University Medical Center, Tenn Vanderbilt Center for Health Services Research
George E NelsonVanderbilt University Medical Center
Allison B McCoyVanderbilt University Medical Center
Todd W RiceVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center
Elizabeth J PhillipsVanderbilt University Medical Center, Vanderbilt University School of Medicine, Tenn Institute for Immunology & Infectious Diseases, Murdoch University
Cosby A StoneVanderbilt University Medical Center
  • 1 - 11

Datasets

Release 1.2